Trial NCT02880371

View at ClinicalTrials.gov 
Org. Study IDs: ARRAY-382-201
Secondary IDs: C4261001

Last trial update was posted on 2022-06-16

MeSH Interventions

Pembrolizumab

MeSH Conditions

Neoplasms

Other Conditions

Advanced Solid Tumors

Stopping Reasons

Study was halted prematurely due to insufficient efficacy. Not due to safety reasons.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID